Top-News

CalciMedica Aktie News

Aktie
WKN:  ISIN:  US38942Q2021 US-Symbol:  CALC Branche:  Biotechnologie Land:  USA
4,37 $
-0,2 $
-4,38%
3,7531 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
19,68%
KGV
-3,31
Index-Zuordnung
-

CalciMedica News

12.11.25 - PR Newswire
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates PR Newswire
12.11.25 - PR Newswire
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension PR Newswire
10.11.25 - PR Newswire
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025 PR Newswire
14.10.25 - PR Newswire
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™ PR Newswire
02.09.25 - PR Newswire
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference PR Newswire
12.08.25 - PR Newswire
CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates PR Newswire
08.07.25 - PR Newswire
CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference
CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference PR Newswire
25.06.25 - PR Newswire
CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure
CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure ...
12.06.25 - PR Newswire
CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting
CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-​CRRT-EBPT and Critical Care Nephrology Meeting PR Newswire
14.05.25 - PR Newswire
CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates PR Newswire
17.04.25 - PR Newswire
CalciMedica Announces Presentations at Upcoming Medical Meetings
CalciMedica Announces Presentations at Upcoming Medical Meetings PR Newswire
01.04.25 - PR Newswire
CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference
CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference PR Newswire
27.03.25 - PR Newswire
CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates PR Newswire
05.03.25 - PR Newswire
CalciMedica Secures Credit Facility for Up to $32.5 Million
CalciMedica Secures Credit Facility for Up to $32.5 Million PR Newswire
19.02.25 - PR Newswire
CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference
CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference PR Newswire
03.02.25 - PR Newswire
CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference PR Newswire
14.01.25 - PR Newswire
CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors
CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors PR Newswire

Newssuche

Videos

newspaper
05.12.25 +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »